North China Pharmaceutical Company.,Ltd.’s Net Profit Dropped 1.5% in First Half of 2023

North China Pharmaceutical Company.,Ltd. (华北制药股份有限公司) (600812.SH) reported a net profit of 42.8 million yuan in the first half of 2023, down 1.5% year-on-year.

Meanwhile, the company posted 5.2 billion yuan in revenue, down 0.9% year-on-year.

At the end of the reporting period, it had 21.1 billion yuan in total assets and 14.9 billion yuan in total liabilities, with a liability-to-asset ratio of 70.4%.